Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery

Seyedeh Roya Alizadeh1, Seyedeh Mahdieh Hashemi2

  • 1Student Research Committee, Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Insights

Researchers explored 2-aminothiazole compounds as novel anticancer agents to overcome drug resistance. These small molecules show potent activity against various cancer cell lines, offering potential for new cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Oncology

Background:

  • Anticancer drug resistance limits the effectiveness of current treatments for prevalent malignant diseases.
  • There is a critical need for novel small molecule antitumor agents with reduced side effects and improved efficacy.
  • The 2-aminothiazole scaffold is a recognized privileged structure in medicinal chemistry, present in approved anticancer drugs.

Purpose of the Study:

  • To review recent advancements in the structural modification of 2-aminothiazole derivatives for enhanced anticancer activity.
  • To summarize the in vitro biological activities of 2-aminothiazole analogs against diverse human cancer cell lines.
  • To highlight the role of in silico studies in the design and development of novel 2-aminothiazole-based anticancer agents.

Main Methods:

  • Comprehensive literature survey on 2-aminothiazole derivatives and their anticancer properties.
  • Analysis of structure-activity relationships (SAR) for various 2-aminothiazole analogs.
  • Review of in vitro experimental data and in silico computational studies.

Main Results:

  • Numerous 2-aminothiazole analogs demonstrate potent and selective nanomolar inhibitory activity against a broad spectrum of cancer cell lines (breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, prostate).
  • Structural modifications of the 2-aminothiazole core have led to compounds with significant antitumor potential.
  • In vitro and in silico investigations support the therapeutic promise of this chemical class.

Conclusions:

  • The 2-aminothiazole scaffold is a valuable platform for developing next-generation anticancer drugs.
  • Continued research into structural modifications and biological evaluation of 2-aminothiazole derivatives is warranted.
  • This review provides a foundation for future innovation in the design of effective anticancer agents targeting drug resistance.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
635
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.1K